摘要
目的:探讨哮喘息儿外周血分化群(CD)56、CD25水平检测的临床意义。方法:应用流式细胞仪(FCM)检测哮喘患儿外周血单个核细胞中CD56+、CD25+细胞数。结果:缓解期组CD56十细胞数百分比[(12.0±3.1)%]及CD25+细胞数百分比[(4.1±2.2)%]与正常对照组比较均无显著性差异(P>0.05);哮喘发作组CD56+细胞数百分比[(9、4±2.2)%]低于正常对照组[(11.9±3.2)%]及缓解期组(P<0.01);哮喘发作组CD25+细胞数百分比[(7.2±2.1)%]高于正常对照组[(4.1±1.8)%]及缓解期组(P<0.01)。结论:CD56+、CD25+细胞数与小儿哮喘的发病过程有一定关系。
Objective:To evaluate the clinical significance of peripheral blood CD 56, CD 25 levels in asthmaticchildren. Methods:The percentage of peripheral blood mononuclear cells CD 56+, CD 25+ cells of asthmatic childrenwere assayed by means of a flow cytometric assay. Results:The percentage of CD 56+ cells [ (12.0±3.1) %] and CD25+ cells [(4.1±2. 2) %] in remission stage had no significant difference compared with the control (P>0. 05);thepercentage of CD 56+ cells in acute attack [(9. 4±2.2) %] was significantly lower than that of the control [(11. 9±3. 2) %] and that of the remission (P<0.01), while the percentage of CD 25+ cells [ (7.2±2. 1) %] in acute attackwas significantly higher than that of the control [(4.1±1. 8) %] and that of the remission (P<0.01).Conclusiou:The percentage of CD 56+and CD 25+ cells are at least partly related to the development of childhood asthma.
出处
《新医学》
1999年第9期514-515,共2页
Journal of New Medicine